Di Filippo Clara, Cuzzocrea Salvatore, Rossi Francesco, Marfella Raffaele, D'Amico Michele
Department of Experimental Medicine, Second Univeristy of Naples, Naples, Italy.
Cardiovasc Drug Rev. 2006 Summer;24(2):77-87. doi: 10.1111/j.1527-3466.2006.00077.x.
The risk factors, such as hypertension and metabolic syndrome, tend to promote heart pathology. These risk factors can aggravate concomitant heart insults as well. Diabetes mellitus represents one of the most important risk factors for the development of heart pathology. By itself it represents a source of vascular and heart dysfunction through formation of reactive oxygen species (ROS) and can compromise the recovery from cardiovascular diseases. This review focuses on the evidence that cellular oxidative stress is the leading cause of the worst outcome of myocardial infarction (MI) in diabetics. Hyperglycemia is viewed in this article as the primary mediator of a cascade of heart damaging events, starting from ROS formation and leading to myocardial ischemia, inflammation and death of myocytes. This article also provides insights into why diverse therapeutic interventions, which have in common the ability to reduce oxidative stress and inflammation, can impede or delay the onset of complications of myocardial infarction in diabetic patients.
高血压和代谢综合征等风险因素往往会促发心脏病变。这些风险因素也会加重伴随的心脏损伤。糖尿病是心脏病变发展的最重要风险因素之一。其本身通过活性氧(ROS)的形成成为血管和心脏功能障碍的一个根源,并会影响心血管疾病的恢复。本综述聚焦于细胞氧化应激是糖尿病患者心肌梗死(MI)最糟糕预后的主要原因这一证据。本文将高血糖视为一系列心脏损伤事件的主要介导因素,这些事件始于ROS的形成,进而导致心肌缺血、炎症和心肌细胞死亡。本文还深入探讨了为何各种具有降低氧化应激和炎症能力的治疗干预措施能够阻碍或延缓糖尿病患者心肌梗死并发症的发生。